Dermatology News

• In the Aftermath of Medical Errors: Podcast Dives Deep A new storytelling podcast explored shame among clinicians, in an effort to offer healthcare professionals space to explore their own experiences.
  Medscape Medical News, October 04, 2022
• Breakthrough Studies Support New Boosters in Immunosuppressed The findings of two studies underscore the importance of booster vaccine doses in those with immune-mediated inflammatory diseases who are taking immunosuppressants.
  Medscape Medical News, October 04, 2022
• Monkeypox Includes Mucocutaneous Involvement in Almost All Cases Systemic features usually but not always precede cutaneous involvement, which is seen in more than 90% of patients, according to Alba Català, MD.
  MDedge News, October 04, 2022
• Childhood Peanut Allergy Linked With Other Legume Allergies French children with peanut allergy also tend to have allergies to one or more other legumes, which are likely to cause anaphylactic reactions, researchers in France report.
  Medscape Medical News, October 04, 2022
• EADV 2022 Ruxolitinib Repigments Many Vitiligo Affected Body Areas A pooled analysis of the TRuE-V1/TRuE-V2 phase 3 trials has shown that ruxolitinib (Opzelura) can help repigment the skin in multiple body areas, with lasting effects even in difficult areas.
  Medscape Medical News, October 03, 2022
• EADV 2022 Data Show Lebrikizumab Atopic Dermatitis Effects Maintained Lebrikizumab shows good long-term efficacy and reasonable safety in patients with moderate to severe atopic dermatitis according to the 52-week results from the phase 3 ADvocate1 and ADvocate2 trials.
  Medscape Medical News, September 30, 2022
• Image-Guided Superficial Radiation as First-line in Skin Cancer? For non-melanoma skin cancer, image-guided superficial radiation therapy offered comparable disease control to Mohs surgery. The study was published as a preprint and has not yet been peer reviewed.
  First Look, September 30, 2022
• Hormones' Impact Described in Transgender Rheumatology Patients Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new case series and systematic review said.
  Medscape Medical News, September 30, 2022
• Sex Differences Seen in Inflammatory Arthritis Healthcare Use Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher in female patients with inflammatory arthritis.
  Medscape Medical News, September 30, 2022
• EADV 2022 BREEZE-AD-PEDS: First Data for Baricitinib in Childhood Eczema The first pediatric trial of baricitinib for childhood eczema suggests that symptoms improve, and the safety profile is similar to that seen in adults.
  Medscape Medical News, September 30, 2022
• Early Data Suggest Vaccine Protects Against Monkeypox People who received a single dose of the vaccine were 14 times less likely to be infected with monkeypox virus, but the findings come with caveats.
  Medscape Medical News, September 29, 2022
• Why Private Practice Will Always Survive Although the majority of physicians are employed, many doctors are leaving employment to start a private practice. Seven physicians talk about why they chose private practice over employment.
  Medscape Medical News, September 29, 2022
• Alert FDA Approves Dupilumab for Treatment of Prurigo Nodularis In phase 3 trials, patients showed clinically meaningful reductions in itchiness and skin lesions with dupilumab compared with placebo.
  Medscape Medical News, September 29, 2022
• EADV 2022 Alopecia Areata: Positive Data Reported for Two JAK Inhibitors JAK inhibitor therapy is hailed as "transformative" for patients with alopecia areata by one of the investigators reporting study results.
  Medscape Medical News, September 29, 2022
• USPSTF: Screen At-Risk, Nonpregnant People for Syphilis Providers should continue screening sexually active, nonpregnant adolescents and adults for syphilis, according to a United States Preventive Services Task Force report.
  Medscape Medical News, September 28, 2022
• Poll: Do Doctors Come to Work Sick? Whereas physicians coming to work sick was fairly common in the past, has the COVID pandemic changed the culture of coming to work while feeling ill?
  Medscape Reader Polls, September 28, 2022
• EADV 2022 Study Identifies Skin Biomarkers That Predict Newborn Eczema Risk During the first 2 months of life, changes in skin biomarkers were predictive of whether children would develop atopic dermatitis up to 2 years later.
  Medscape Medical News, September 28, 2022
• Female Docs Rarely Earn Highest Drug, Device Payouts: Study A new study finds gender disparities common in industry payouts, resulting in female physicians earning less and having fewer opportunities to network and advance their careers.
  Medscape Medical News, September 28, 2022
• Psoriasis, PsA Insurance Coverage Remains Restrictive A database review showed restrictive coverage of specialty medications for psoriatic disease beyond the label indications.
  MDedge News, September 27, 2022
• ESMO 2022 Neoadjuvant Immunotherapy Shows Promise for Resectable CSCC Some patients develop more advanced cancer that requires surgery, often on exposed surfaces like the scalp, face, or neck.
  Medscape Medical News, September 27, 2022